ERNA
Price:
$1.96
Market Cap:
$14.43M
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
Industry
Biotechnology
IPO Date
1991-08-29
Stock Exchange
NASDAQ
Ticker
ERNA
According to Eterna Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 316.97%. This represents a change of -1741.07% compared to the average of -19.31% of the last 4 quarters.
The mean historical ROE of Eterna Therapeutics Inc. over the last ten years is -584.04%. The current 316.97% ROE has changed -154.27% with respect to the historical average. Over the past ten years (40 quarters), ERNA's ROE was at its highest in in the March 2021 quarter at 400.39%. The ROE was at its lowest in in the September 2021 quarter at -659.92%.
Average
-584.04%
Median
-129.82%
Minimum
-2618.40%
Maximum
155.45%
Discovering the peaks and valleys of Eterna Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 973.82%
Maximum Annual ROE = 155.45%
Minimum Annual Increase = -1310.06%
Minimum Annual ROE = -2618.40%
Year | ROE | Change |
---|---|---|
2024 | -2618.40% | 169.84% |
2023 | -970.35% | 377.97% |
2022 | -203.01% | -89.21% |
2021 | -1881.05% | -1310.06% |
2020 | 155.45% | -486.62% |
2019 | -40.21% | 973.82% |
2018 | -3.74% | -80.75% |
2017 | -19.45% | -72.92% |
2016 | -71.85% | -61.74% |
The current ROE of Eterna Therapeutics Inc. (ERNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1263.92%
5-year avg
-1103.47%
10-year avg
-584.04%
Eterna Therapeutics Inc.’s ROE is greater than iTeos Therapeutics, Inc. (-21.36%), greater than Cardio Diagnostics Holdings, Inc. (-84.56%), greater than Annexon, Inc. (-54.45%), greater than bioAffinity Technologies, Inc. (-367.64%), greater than PaxMedica, Inc. Common Stock (-1367.11%), greater than Revelation Biosciences, Inc. (-505.44%), greater than Entero Therapeutics, Inc. (-39.02%), greater than Pharvaris N.V. (-54.35%),
Company | ROE | Market cap |
---|---|---|
-21.36% | $396.13M | |
-84.56% | $7.69M | |
-54.45% | $286.35M | |
-367.64% | $8.16M | |
-1367.11% | $12.56K | |
-505.44% | $1.86M | |
-39.02% | $2.30M | |
-54.35% | $1.30B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eterna Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eterna Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Eterna Therapeutics Inc.'s ROE?
How is the ROE calculated for Eterna Therapeutics Inc. (ERNA)?
What is the highest ROE for Eterna Therapeutics Inc. (ERNA)?
What is the 3-year average ROE for Eterna Therapeutics Inc. (ERNA)?
What is the 5-year average ROE for Eterna Therapeutics Inc. (ERNA)?
How does the current ROE for Eterna Therapeutics Inc. (ERNA) compare to its historical average?